IRIDEX Profit Margin

The latest profit margin for IRIX is -6.88% as of June 2026. That compares with -10.95% in the prior-year period — up 37.2% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside IRIDEX's historical trend and sector peers before judging valuation or financial health.

Over the past year, IRIX's profit margin moved from -10.95% to -6.88% — a 37.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IRIDEX's valuation or profitability profile.

Against Healthcare companies, IRIX currently prints -6.88% for profit margin, while the sector average sits near 21.34%. That is roughly 132.2% below the sector mean. Large gaps often invite a closer look at IRIDEX's growth, margins, and balance sheet.

Profit Margin shows how effectively IRIDEX converts resources into returns. At -6.88%, IRIX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -10.95% in the prior-year period — up 37.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IRIX's profit margin (-6.88%), review year-over-year change from -10.95%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.